Hunan Hansen Pharmaceutical Co., Ltd.
CN¥7.48+CN¥0.03 (+0.4%)
Hunan Hansen Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.43% below the high.
SHZ · 300636.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Jiangxi Synergy Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.97% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jiangxi Synergy Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.04 per share, paid annual. The forward yield is 0.62% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jiangxi Synergy Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Yichun, People's Republic of China, Jiangxi Synergy Pharmaceutical Co., Ltd. was established in 2004. The company specializes in the global production and sale of active pharmaceutical ingredients (APIs), as well as liquid crystal compounds and various chemical intermediates.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥7.48+CN¥0.03 (+0.4%)
Hunan Hansen Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.43% below the high.
CN¥5.82+CN¥0.02 (+0.34%)
Shandong Wohua Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.29% below the high.
CN¥5.04-CN¥0.26 (-4.91%)
PKU HealthCare Corp.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.92% below the high.
CN¥4.72-CN¥0.11 (-2.28%)
Baotou Dongbao Bio-Tech Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 30.79% below the high.
CN¥14.60-CN¥0.26 (-1.75%)
Tibet AIM Pharm. Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.04% below the high.
CN¥11.33-CN¥0.05 (-0.44%)
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.9% below the high.
CN¥19.41-CN¥0.09 (-0.46%)
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.15% below the high.
CN¥3.19CN¥0.00 (0.0%)
Guizhou Yibai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.47% below the high.